atherogenic


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

ath·er·o·gen·ic

(ath'er-ō-jen'ik),
Having the capacity to initiate, increase, or accelerate the process of atherogenesis.

atherogenic

adjective Referring to the ability to initiate or accelerate atherogenesis (the deposition of atheromas, lipids and calcium in the arterial lumen).

atherogenic

adjective Referring to the ability to initiate or accelerate atherogenesis—the deposition of atheromas, lipids, and calcium in the arterial lumen

ath·er·o·gen·ic

(ath'ĕr-ō-jen'ik)
Having the capacity to initiate, increase, or accelerate the process of atherogenesis.
References in periodicals archive ?
A previous study evaluated the influence of shift work on different atherogenic indices including TG/HDL ratio, TC/HDL ratio, and LDL-C/HDL ratio.
Moreover, it will also address the underlying CVD risk concepts of atherogenic dyslipidaemia and CVD risk persisting after anti-cholesterol treatments.
However, the Apolipoprotein B (apoB) concentration reflects the number of atherogenic particles and is closely associated with atherosclerosis.13,14
The DM+NAC group had a lower (p < 0.05) atherogenic index than the DM group.
pylori can increase the level of LDL and FBS in seropositive male patients; the bacteria also play a role in the incidence of coronary artery disease through affecting atherogenic lipid profile and blood sugar level; but, in seropositive female patients, considering the lower levels of TG, it seems that the atherogenic effect of H.
DT2 Spearman t (n-2) P ([r.sub.s]) Anxiety level and HEX -0.19 -1.18 0.25 Depression level and HEX -0.16 -1.02 0.31 Cholesterol and HEX 0.22 1.24 0.16 TAG and HEX 0.32 2.06 0.046 * LDL cholesterol and HEX 0.37 2.46 0.02* HDL cholesterol and HEX -0.31 -1.99 0.05 Castelligro atherogenic index 0.41 2.80 0.008 ** and HEX
AIP is superior to other traditional assessment indexes (e.g., cardiogenic risk ratio and atherogenic coefficient) in assessing risk for CV events [14].
(20,22) The most recent study was a six month prospective trial that investigated the effects of a Bergamot extract on cardio-metabolic parameters, including plasma lipids, atherogenic lipoproteins and subclinical atherosclerosis.
This is confirmed by the reduction in the atherogenic and thrombogenic indexes.